Epidemiology of male breast cancer.

Breast cancer in men is a rare disease, accounting for approximately 1% of all breast cancer cases. Although the epidemiologic literature regarding female breast cancer is extensive, relatively little is known about the etiology of male breast cancer (MBC). This review is intended to summarize the existing body of evidence on genetic and epidemiologic risk factors for breast cancer in men. Overall, the epidemiology of MBC presents similarities with the epidemiology of female breast cancer. Major genetic factors associated with an increased risk of breast cancer for men include BRCA2 mutations, which are believed to account for the majority of inherited breast cancer in men, Klinefelter syndrome, and a positive family history. Suspected genetic factors include AR gene mutations, CYP17 polymorphism, Cowden syndrome, and CHEK2. Epidemiologic risk factors for MBC include disorders relating to hormonal imbalances, such as obesity, testicular disorders (e.g., cryptorchidism, mumps orchitis, and orchiectomy), and radiation exposure. Suspected epidemiologic risk factors include prostate cancer,prostate cancer treatment, gynecomastia, occupational exposures (e.g., electromagnetic fields, polycyclic aromatic hydrocarbons, and high temperatures), dietary factors (e.g., meat intake and fruit and vegetable consumption), and alcohol intake.

[1]  M. Stratton,et al.  An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer. , 1998, Cancer research.

[2]  G. Hortobagyi,et al.  Breast carcinoma in men , 2004, Cancer.

[3]  D. Easton,et al.  Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancers , 2004, International journal of cancer.

[4]  E. Gorgun,et al.  Anthropometric Measurements in Male Breast Cancer , 2002, Obesity surgery.

[5]  F. Perera,et al.  Carcinogen-DNA adducts in human breast tissue. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  O. Scheike Male Breast Cancer , 1973, British Journal of Cancer.

[7]  B. Ponder,et al.  No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. , 1998, British Journal of Cancer.

[8]  E D Brown,et al.  Serum hormones and the alcohol-breast cancer association in postmenopausal women. , 2001, Journal of the National Cancer Institute.

[9]  M. Stratton,et al.  A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome , 1992, Nature Genetics.

[10]  D A Savitz,et al.  Magnetic field exposure in relation to leukemia and brain cancer mortality among electric utility workers. , 1995, American journal of epidemiology.

[11]  J. Pontes,et al.  Metastatic prostatic carcinoma to breast or primary breast carcinoma? , 1982, Urology.

[12]  J. Vena,et al.  Occupational exposures associated with male breast cancer. , 1994, American journal of epidemiology.

[13]  R. Stevens,et al.  Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.

[14]  G. Matanoski,et al.  Electromagnetic field exposure and male breast cancer , 1991, The Lancet.

[15]  C. Johansen,et al.  Risk of cancer among Danish utility workers--a nationwide cohort study. , 1998, American journal of epidemiology.

[16]  A. Auquier,et al.  Risk factors for male breast cancer: A Franco‐Swiss case‐control study , 1990, International journal of cancer.

[17]  A. Sasco,et al.  Review article: Epidemiology of male breast cancer. A meta‐analysis of published case‐control studies and discussion of selected aetiological factors , 1993, International journal of cancer.

[18]  H. Olsson,et al.  Male gynecomastia and risk for malignant tumours – a cohort study , 2002, BMC Cancer.

[19]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[20]  K. Lamperska,et al.  BRCA2 germline mutations in male breast cancer patients in the Polish population , 2001, Human mutation.

[21]  J. Ranstam,et al.  Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. , 1988, Journal of the National Cancer Institute.

[22]  Robert Kavet,et al.  The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: A review of the relevant literature , 1999, Journal of pineal research.

[23]  Birgitta Floderus,et al.  Occupational exposure to magnetic fields in relation to male breast cancer and testicular cancer: a Swedish case-control study , 1997, Cancer Causes & Control.

[24]  P. Redlich,et al.  Breast cancer in men. , 1996, The Surgical clinics of North America.

[25]  D. Vågerö,et al.  Incidence of cancer in the electronics industry: using the new Swedish Cancer Environment Registry as a screening instrument. , 1983, British journal of industrial medicine.

[26]  B. Petersen,et al.  Male breast cancer. 3. Breast carcinoma in association with the Klinefelter syndrome. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[27]  M. Pike,et al.  Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. , 1998, Cancer research.

[28]  K. Kurian,et al.  The CAG repeat within the androgen receptor gene in male breast cancer patients , 2000, Journal of medical genetics.

[29]  T. Erren,et al.  A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. , 2001, Bioelectromagnetics.

[30]  F. Speizer,et al.  Alcohol and breast cancer in women: a pooled analysis of cohort studies. , 1998, JAMA.

[31]  T. Tynes,et al.  Incidence of cancer in Norwegian workers potentially exposed to electromagnetic fields. , 1992, American journal of epidemiology.

[32]  Wolfgang Ahrens,et al.  Alcohol Drinking May Increase Risk of Breast Cancer in Men: A European Population-Based Case–Control Study , 2004, Cancer Causes & Control.

[33]  D. Bull,et al.  Cancer in electrical workers: an analysis of cancer registrations in England, 1981-87. , 1996, British Journal of Cancer.

[34]  T. Hayes,et al.  Male breast cancer: a review of the literature. , 1998, European journal of cancer.

[35]  J Newman Breast cancer in men and mammography of the male breast. , 1997, Radiologic technology.

[36]  H. Sã¸Rensen Risk of Breast Cancer in Men With Liver Cirrhosis , 1998 .

[37]  A. Auvinen,et al.  Androgen Receptor Gene Alterations in Finnish Male Breast Cancer , 2004, Breast Cancer Research and Treatment.

[38]  J. Hansen Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. , 2000, American journal of industrial medicine.

[39]  Sean V Tavtigian,et al.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  B. Ponder,et al.  High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. , 1999, Cancer research.

[41]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[42]  R. Mariani-Costantini,et al.  BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. , 2003, Cancer research.

[43]  E. Gubéran,et al.  Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. , 1989, British journal of industrial medicine.

[44]  P. V. van Diest,et al.  Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men. , 2000, The American journal of surgical pathology.

[45]  O. Olopade,et al.  Male breast cancer in Cowden syndrome patients with germlinePTEN mutations , 2001, Journal of medical genetics.

[46]  B. Ponder,et al.  Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. , 1997, American journal of human genetics.

[47]  M. Kelsh,et al.  Mortality among a cohort of electric utility workers, 1960-1991. , 1997, American journal of industrial medicine.

[48]  K. Helzlsouer,et al.  Breast cancer epidemiology, prevention, and early detection , 2001, Current opinion in oncology.

[49]  R. Jackson,et al.  Breast cancer in men. , 2003, Annals of internal medicine.

[50]  R. Hultborn,et al.  Prevalence of Klinefelter's syndrome in male breast cancer patients. , 1997, Anticancer research.

[51]  The Polish Breast Cancer Consortium Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002 .

[52]  D E Goldgar,et al.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.

[53]  Douglas F Easton,et al.  BRCA1 and BRCA2 mutations in a population-based study of male breast cancer , 2001, Breast Cancer Research.

[54]  A. Ellis Breast , 2002, BMJ : British Medical Journal.

[55]  J. B. Andersen,et al.  Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark. , 1993, British journal of industrial medicine.

[56]  Birgitta Floderus,et al.  Occupational magnetic field exposure and site-specific cancer incidence: a Swedish cohort study , 1999, Cancer Causes & Control.

[57]  J. Struewing,et al.  Founder BRCA1/2 mutations among male patients with breast cancer in Israel. , 1999, American journal of human genetics.

[58]  G. Hortobagyi,et al.  Male breast cancer , 1998, The Lancet.

[59]  M. Greene,et al.  Genetics of breast cancer. , 1997, Mayo Clinic proceedings.

[60]  J. Andersen,et al.  Male breast at autopsy. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology.

[61]  D. Loomis,et al.  Cancer of breast among men in electrical occupations , 1992, The Lancet.

[62]  H. Adami,et al.  Breast cancer risk in male alcoholics in Sweden , 2004, Cancer Causes & Control.

[63]  F. Rousseau,et al.  Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. , 2001, Cancer research.

[64]  Crichlow Rw Carcinoma of the male breast. , 1972, Surgery, gynecology & obstetrics.

[65]  H. Würz,et al.  Klinefelter's Syndrome and Breast Cancer , 2009, Andrologia.

[66]  J. Little,et al.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. , 1994, Human molecular genetics.

[67]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[68]  K. Kurian,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1999.0663 Short Communication , 2022 .

[69]  J. Bringer,et al.  Androgen receptor gene mutation in male breast cancer. , 1993, Human molecular genetics.

[70]  D. Thomas,et al.  Breast cancer in men: risk factors with hormonal implications. , 1992, American journal of epidemiology.

[71]  C. la Vecchia,et al.  Risk factors for male breast cancer. , 1995, British Journal of Cancer.

[72]  O. Schlappack,et al.  Report of two cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma. , 1986, Cancer detection and prevention.

[73]  D. Easton,et al.  Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. , 2001, American journal of human genetics.

[74]  J. Jónasson,et al.  CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status , 2003, British Journal of Cancer.

[75]  W. Benson Carcinoma of the prostate with metastases to breasts and testis critical review of the literature and report of a case , 1957, Cancer.

[76]  K. Rosenblatt,et al.  The relationship between diet and breast cancer in men (United States) , 1999, Cancer Causes & Control.

[77]  P. Tonin,et al.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? , 1997, American journal of human genetics.

[78]  E. Friedman,et al.  CHEK2*1100delC and male breast cancer risk in Israel , 2004, International journal of cancer.

[79]  A. Lilienfeld,et al.  Some observations on the epidemiology of breast cancer among males. , 1963, American journal of public health and the nation's health.

[80]  B. Floderus,et al.  Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men. , 2001, American journal of industrial medicine.

[81]  A. Keller Demographic, clinical and survivorship characteristics of males with primary cancer of the breast. , 1967, American journal of epidemiology.

[82]  O. Kallioniemi,et al.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.

[83]  S. Pan,et al.  Risk factors for male breast cancer in Canada, 1994–1998 , 2002, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[84]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[85]  S. Törnqvist,et al.  Incidence of selected cancers in Swedish railway workers, 1961–79 , 1994, Cancer Causes & Control.

[86]  D. Sgroi,et al.  Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. , 2001, Cancer research.

[87]  B. V. Pedersen,et al.  Risk factors for male breast cancer--a case-control study from Scandinavia. , 2001, Acta oncologica.

[88]  Henrik Grönberg,et al.  Second primary cancers in men with prostate cancer: an increased risk of male breast cancer. , 2003, The Journal of urology.

[89]  Spratt Js,et al.  Assessing the risk of breast cancer. , 2000 .

[90]  Å. Borg,et al.  BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. , 1998, Cancer research.

[91]  P. Schauer,et al.  Male breast cancer following repeated fluoroscopy. , 1984, The American journal of medicine.

[92]  J. Fischer,et al.  Breast cancer in brothers Case reports and a review of 30 cases of male breast cancer , 1975, Cancer.

[93]  Douglas B. Evans,et al.  Carcinoma of the male breast and klinefelter's syndrome: Is there an association? , 1987, CA: a cancer journal for clinicians.

[94]  S C West,et al.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. , 2001, Molecular cell.

[95]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[96]  G Thériault,et al.  Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada, and France: 1970-1989. , 1994, American journal of epidemiology.

[97]  J. Fraumeni,et al.  Risk Factors for Male Breast Cancer (United States) , 1998, Cancer Causes & Control.

[98]  M. Robson,et al.  Localized male breast carcinoma and family history , 1999, Cancer.

[99]  C. T. Curtin,et al.  Thyroid and breast cancer following childhood radiation , 1977, Cancer.

[100]  I. Ganly,et al.  Breast cancer in a trans‐sexual man receiving hormone replacement therapy , 1995, The British journal of surgery.

[101]  L. Sobin,et al.  Relation between male breast cancer and prostate cancer. , 1980, British Journal of Cancer.

[102]  S. Narod,et al.  The genetic epidemiology of male breast carcinoma , 1999, Cancer.

[103]  A. Ahlbom,et al.  Cancer morbidity among workers in the telecommunications industry. , 1985, British journal of industrial medicine.

[104]  C. la Vecchia,et al.  Alcohol consumption and risk of breast cancer: a multicentre Italian case-control study. , 1998, European journal of cancer.

[105]  D. Thomas,et al.  Breast cancer in men: aspects of familial aggregation. , 1991, Journal of the National Cancer Institute.

[106]  I. Barshack,et al.  Genetic analyses of male breast cancer in Israel. , 2000, Genetic testing.

[107]  J. Eyfjörd,et al.  Study of a single BRCA2 mutation with high carrier frequency in a small population. , 1997, American journal of human genetics.

[108]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[109]  F. Abdul-Karim,et al.  Breast cancer in a male-to-female transsexual. A case report. , 1988, JAMA.

[110]  W. Symmers,et al.  Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. , 1968, British medical journal.

[111]  K. Rosenblatt,et al.  Ionizing radiation and breast cancer in men (United States) , 2005, Cancer Causes & Control.

[112]  M. Pike,et al.  A case-control study of male breast cancer. , 1988, Cancer research.

[113]  A. Auvinen,et al.  CHEK2 1100delC is not a risk factor for male breast cancer population , 2004, International journal of cancer.

[114]  A Ahlbom,et al.  Mortality experience of electrical engineers. , 1985, British journal of industrial medicine.

[115]  D. Schottenfeld,et al.  Male Breast Cancer: A Clinicopathologic Study of 97 Cases , 1978, Annals of surgery.

[116]  M Feychting,et al.  Magnetic Fields and Breast Cancer in Swedish Adults Residing near High‐Voltage Power Lines , 1998, Epidemiology.

[117]  M Dosemeci,et al.  Case-control study of occupational exposures and male breast cancer. , 1998, Occupational and environmental medicine.

[118]  J. Rommens,et al.  BRCA2 germline mutations in male breast cancer cases and breast cancer families , 1996, Nature Genetics.

[119]  O. Kallioniemi,et al.  Somatic genetic alterations in BRCA2‐associated and sporadic male breast cancer , 1999, Genes, chromosomes & cancer.

[120]  P. Demers,et al.  Occupational exposure to electromagnetic fields and breast cancer in men. , 1991, American journal of epidemiology.